Table 1.
Chr | SNP ref. no. |
P value | Betaa | Position (BP) |
Function | Minor/major allele |
MAF | Dist. to gene (BP) |
Gene symbol | WGHS cohort |
|
---|---|---|---|---|---|---|---|---|---|---|---|
Allelic P value | Beta (SE) | ||||||||||
Top 10 GWAS SNPS | |||||||||||
4 | rs11930554 | 2.84E−6 | 1.068 | 131787382 | Intergenic | C/T | 0.138 | −359452 | AC092540.1 | 0.35 | 0.026 (0.03) |
4 | rs11936003 | 2.84E−06 | 1.068 | 131788092 | Intergenic | G/A | 0.138 | −360162 | AC092540.1 | 0.35 | 0.026 (0.03) |
4 | rs7690766 | 3.35E−06 | 1.064 | 131774208 | Intergenic | G/A | 0.135 | −346278 | AC092540.1 | 0.37 | 0.025 (0.03) |
9 | rs4977338 | 1.96E−06 | −0.823 | 18718086 | Intronic | T/G | 0.140 | 0 | ADAMTSL1 | 0.48 | −0.022 (0.03) |
9 | rs10512405 | 1.21E−05 | −0.542 | 113236797 | Intronic | C/T | 0.403 | 0 | SVEP1 | 0.18 | −0.032 (0.02) |
10 | rs883248 | 3.83E−06 | 0.666 | 1250184 | Intronic | G/A | 0.439 | 0 | ADARB2 | 0.91 | 0.003 (0.02) |
10 | rs7079024 | 3.03E−06 | 0.630 | 3445668 | Intergenic | C/T | 0.470 | 83418 | RP11−482E14.1 | 0.94 | −0.002 (0.02) |
10 | rs10795033 | 1.72E−05 | 0.578 | 3447072 | Intergenic | C/T | 0.470 | 82014 | RP11−482E14.1 | 0.95 | −0.002 (0.02) |
17 | rs2525570 | 1.15E−05 | 0.603 | 29681245 | Intronic | G/A | 0.469 | 0 | NF1 | 0.78 | 0.006 (0.02) |
19 | rs4807347 | 9.56E−06 | 0.941 | 2857287 | 3Prime UTR | A/C | 0.144 | 0 | ZNF555 | 0.019 | −0.074 (0.03) |
Biologically and statistically prioritised SNPs | |||||||||||
1 | rs6425412 | 0.0002 | 11.25 | 177073727 | Intronic | G/A | 0.034 | 0 | ASTN | 0.24 | 0.055 (0.05) |
2 | rs2600685 | 5.19E−05 | 0.52 | 175627048 | Intronic | A/G | 0.492 | 0 | CHRNA1 | 0.32 | −0.023 (0.02) |
3 | rs11714003 | 0.0003 | −0.78 | 54234467 | Intronic | G/A | 0.089 | 0 | CACNA2D3 | 0.34 | 0.039 (0.04) |
3 | rs1391950 | 2.70E−05 | 0.55 | 7058417 | Intronic | G/A | 0.490 | 0 | GRM7 | 0.77 | −0.007 (0.02) |
3 | rs11713183 | 7.26E−05 | −0.51 | 7078179 | Intronic | T/C | 0.427 | 0 | GRM7 | 0.23 | 0.027 (0.02) |
5 | rs1561836 | 0.0002 | 0.85 | 22794657 | Intronic | C/T | 0.128 | 0 | CDH12 | 0.55 | −0.023 (0.04) |
5 | rs210993 | 0.0002 | 0.50 | 161619504 | Intergenic | A/G | 0.344 | 36959 | GABRG2 | 0.74 | 0.008 (0.02) |
10 | rs10903399 | 7.68E−05 | 0.64 | 1227868 | Downstream | C/T | 0.330 | 205 | ADARB2 | 0.61 | 0.012 (0.02) |
10 | rs1046914 | 3.43E−05 | 0.67 | 1228206 | 3Prime utr | G/A | 0.328 | 0 | ADARB2 | 0.60 | 0.013 (0.02) |
10 | rs2271275 | 2.67E−05 | 0.65 | 1230968 | Non-synon | G/A | 0.368 | 0 | ADARB2 | 0.62 | 0.012 (0.02) |
10 | rs883248 | 3.83E−06 | 0.67 | 1250184 | Intronic | G/A | 0.439 | 0 | ADARB2 | 0.91 | 0.003 (0.02) |
10 | rs2800143 | 0.0002 | −0.65 | 92463214 | Intergenic | A/G | 0.128 | 37366 | HTR7 | NA | NA |
12 | rs11615115 | 4.02E−05 | 3.79 | 100802452 | Intronic | G/A | 0.045 | 0 | SLC17A8 | 0.14 | 0.068 (0.05) |
A negative beta indicates the minor allele increases migraine risk, a positive beta indicates a decreased risk
BP base pairs, Chr chromosome, MAF minor allele frequency, NA not available, WGHS Women’s Genome Health Study
The beta coefficient is a measure of risk